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Hongxia Li1, Qinhe Fan1, Zhen Wang1, Hai Xu2, Xiao Li1, Weiming Zhang1 and Zhihong Zhang1*Abstract
Primary malignant melanoma of the duodenum is an unusual oncologic entity. Patients usually present the similar
clinical symptoms like other common tumors in this site. And there are no specific radiological features either. The
cases with only little melanin pigment or without notable melanin pigment are very misleading, especially in small
biopsies or frozen sections. Definite diagnosis depends on both careful histologic examination and the use of
proper immunohistochemical stains. Moreover, detailed history and thorough investigation should be made to
exclude the preexistence or coexistence of a primary lesion elsewhere. Herein we report the case of a 60-year-old
male patient with primary malignant melanoma of the duodenum, which was misdiagnosed as lymphoma or
undifferentiated carcinoma in frozen consultation. The patient had achieved disease-free survival for more than
46 months without any evidence of recurrence after surgery.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1221457317710561.
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Malignant melanoma, originated from melanocyte, is
not a common tumor and accounts for 1 to 3% of all
malignancies [1]. However, it is the most common meta-
static tumor of the gastrointestinal (GI) tract especially
the small intestine and can present with fairly common
constitutional symptoms [2]. Primary malignant melan-
oma originating in the small bowel, particularly in the
duodenum, is extremely rare and very controversial. In
addition, some cases with little melanin pigment or
without visible melanin pigment are very misleading, es-
pecially in small biopsy specimens or frozen sections.
Identifying areas showing possible melanin pigment and
immunostains with specific markers for melanoma, such
as HMB45, Melan-A and S-100 protein, are diagnostic-
ally important. We encountered a case of primary malig-
nant melanoma of the duodenum (PMMD) without any
visible melanin pigment and misdiagnosed as lymphoma* Correspondence: zhangzhih2001@yahoo.com.cn
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reproduction in any medium, provided the oror undifferentiated carcinoma in frozen consultation, to
highlight its clinic-pathological features and the diagnos-
tic pitfalls.Case presentation
Clinical summary
A 60-year-old Chinese male patient suffering from dura-
tive right abdominal pain and dark stools for one month,
a recent episode of nausea and vomiting, was admitted
to hospital in May 27, 2008. No history of fever, anor-
exia, hematemesis, radiating pain or weight loss was
reported. Upper GI endoscopy revealed a malignant
tumor at the descending part of the duodenum and the
biopsy suspected poorly differentiated carcinoma. But
there were no enough tumor cells for further immuno-
histochemical stain. In physical examination, there was
no any obvious black nevus or nodule, nor swelled
superficial lymph node. Routine hematological and bio-
chemical studies showed no abnormalities. Serum detec-
tion showed tumor markers such as alpha fetoprotein
(AFP), carcinoembryonic antigen (CEA), carbohydrate
antigen 50 (CA-50), carbohydrate antigen 19–9 (CA-19-his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 2 Histological examination (hematoxylin-eosin). (A) The
lesion located under the enteric mucosa with diffusely infiltrative
tumor cells without obvious mucosal destruction (Objective × 4); (B)
The tumor cells showed markedly cytologic atypia with large
eosinophilic nucleoli, abundant mitotic figures and moderate
cytoplasm, however, without visible melanin pigment
(Objective × 40).
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Blood) Testing was positive. GI tract barium meal
revealed a filling defect in the descendant duodenum,
without obvious mucosal destruction and barium passed
smoothly. Computed tomography scan of the abdomen
disclosed the presence of a space-occupying lesion ori-
ginating from the descending part of the duodenum with
stenotic lumens (Figure 1). An exploratory laparotomy
was performed through a midline incision in Jun 2, 2008
and confirmed the presence of a solid tumor arising
from the lateral part of the descendant duodenum,
which invading the duodenal serosa. Enlarged mesentery
lymph node and peripancreatic lymph node were identi-
fied. Because the surgeons suspected the tumor as
lymphoma, so only a palliative operation (tumor resec-
tion) was done.
Pathologic findings
Intraoperative consultation showed a tumor measuring
2.5 cm× 1.5 cm× 1 cm, mesentery lymph node and peri-
pancreatic lymph node measuring 3 cm, 2 cm in diam-
eter respectively. The cut surfaces of the specimens were
both pliable and gray red without pigment. Frozen sec-
tions were applied. Histologically, the lesion located
under the enteric mucosa with diffusely infiltrative
tumor cells, however, without obvious mucosal destruc-
tion (Figure 2A). The tumor cells were round, oval or
polygonal epithelioid, showing markedly cytologic atypia
with large eosinophilic nucleoli, abundant mitotic figures
and moderate cytoplasm. But there was no obviously vis-
ible melanin pigment in cytoplasm (Figure 2B). Mesen-
tery lymph node was positive for tumor cells (1/1),
whereas peripancreatic lymph node was negative (0/1).Figure 1 Computed tomography scan of the abdomen reveals
a space-occupying lesion originating from the descending part
of the duodenum (red arrow).According to above-mentioned features, pathologists
consulted malignant tumor, prone to lymphoma or un-
differentiated carcinoma. And the surgeons thought it
might be lymphoma so only local tumor was resected.
Subsequently, routine hematoxylin-eosin sections (for-
malin-fixed and paraffin-embedded) and immunostains
were done. But the results of immunohistochemical
stains didn’t support the diagnoses of lymphoma and
undifferentiated carcinoma. The tumor cells were
strongly positive for melanoma marker (HMB45),
Melan-A, S-100 protein (Figure 3A-C) and vimentin,
whereas CD20, CD45RO, CD3, CD79α, myeloperoxi-
dase, terminal deoxynucleotidyl transferase, pan cytoker-
atin (AE1/AE3), keratin 5/6, keratin 7, synaptophysin,
chromogranin A, and sarcoma markers such as smooth
muscle actin, desmin, CD117, CD34 were all negative. AFigure 3 Immunohistochemical stains (Envision, Objective × 40).
(A) The tumor cells were positive for HMB45 in cytoplasm; (B) The
tumor cells were positive for Melan-A in cytoplasm; (C) The tumor
cells were positive for protein S-100 protein in both nucleus and
cytoplasm; (D) Ki-67 immunostaining showed a proliferative index of
60%.
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nostaining (Figure 3D). So the diagnosis of malignant
melanoma was confirmed.
Thorough postoperative systemic evaluations including
a detailed history, clinical examination, endoscopic as-
sessment, and radiologic imaging were done to rule out
the presence of a primary cutaneous, anal, or ocular le-
sion, or a melanoma in any other site; however, no pri-
mary site was found. Therefore, the resected tumor was
determined to represent a PMMD with mesentery lymph
node metastasis. The patient refused chemotherapy and
just used Chinese traditional medicine treatment inter-
mittently to improve the immunity. Close follow-up
showed that the patient is doing well with no evidence
of loco regional recurrence or distant metastasis for
more than 46 months after surgery.Discussion
Malignant melanoma is a relatively rare tumor compris-
ing 1-3% of all tumors and exhibits an unusual tendency
to metastasize to the GI tract [3]. Although frequently
seen in autopsy series in up to 50 to 60% of patients,
only 2 to 5% of patients are diagnosed with metastatic
malignant melanoma to the GI tract while they are still
alive [4]. It is because that there are no specific symp-
toms of early development, which are general and con-
stitutional; and even if metastases do occur, they are
usually accompany with symptoms such as abdominal
pain (62%), hemorrhage (50%), nausea and vomiting
(26%), mass (22%), intestinal obstruction (18%), or intus-
susceptions (15%), and are frequently diagnosed in an
emergency situation [5]. Metastasis to the GI tract is
seen most frequently in the small intestine, followed by
the colon, stomach, and rectum, but is rare in the
esophagus. However, primary malignant melanoma ori-
ginating in the small intestine and particularly in the
duodenum is extremely rare, with only a few case
reports [1,6,7].
There are different theories concerning the origin of
primary malignant melanoma in the small bowel, though
the controversy still exists over the presence of primary
malignant melanoma in this area. Some proposes that
malignant melanoma may originate from neural crest
cells. These multipotential cells migrate through the
body and can get to the bowel via the umbilical-
mesenteric canal, where they later differentiate into spe-
cialized cells [8]. Although not consistently confirmed,
another theory suggests that malignant melanoma might
potentially develop from amine precursor uptake and
decarboxylation (APUD) cells [9]. Besides, it is presumed
that the small intestine normally contains melanoblasts,
which may support the assumption of primary develop-
ment of melanoma at this site.Before making the diagnosis of primary malignant
melanoma of the small bowel, thorough systemic exam-
ination must be done to rule out the possibility of me-
tastasis from other sites, which may preferentially
develop on the skin, retina, anal canal, or under the nail,
and less frequently at other locations such as the
esophagus, penis, or vagina. In addition, there should be
no history of previous removal or spontaneous regres-
sion of any atypical melanocytic skin tumor [10]. The
following diagnostic criteria have been occasionally pro-
posed. According to Sachs et al. [8], primary malignant
melanoma in the small bowel is diagnosed where there
are: 1) biopsy-proven melanoma from the intestine at a
single focus; 2) no evidence of disease in any other
organs including the skin, eye and lymph nodes outside
the region of drainage at the time of diagnosis; and 3)
disease-free survival of at least 12 months after diagno-
sis. According to Blecker [2], it is diagnosed when there
is lack of concurrent or previous removal of a melanoma
or melanocytic lesion from the skin and lack of any
other organ involvement and in situ change in the over-
lying or adjacent GI epithelium. In this case, one single
focus located in the lateral of the descendant duodenum,
and thorough postoperative investigation including a
detailed history, clinical examination, endoscopic assess-
ment, and radiologic imaging failed to reveal any evi-
dence of a pre-existing primary tumor or any other
metastatic lesion. Moreover, the patient has survived for
more than 46 months with no evidence of loco regional
recurrence or distant metastasis. Thus, we felt confident
in supporting the diagnosis of PMMD.
Although the possibility of primary malignant melan-
oma in the small intestine does exist, the incidence is ex-
tremely low. In addition, melanoma by itself is a great
mimicker of other neoplastic conditions [11]. It is very
easy to diagnose for the cases with obvious melanin pig-
ment, but sometimes, the specimen only with little pig-
ment or without any visible pigment, which may create a
major diagnostic challenge, must be differentiated from
other common intestinal tumors like lymphoma, carcin-
oma of poor differentiation, neuroendocrine tumor, leio-
myosarcoma, GIST (Gastrointestinal Stromal Tumor),
et al. More sections as far as possible and careful obser-
vation can help to find valuable diagnositic clues. Fur-
thermore, immunohistochemical staining and electron
microscope detection may play an important role for dif-
ferential diagnosis. In our patient, the initial frozen sec-
tions revealed the tumor cells were relatively uniform
with markedly cytologic atypia and abundant mitotic fig-
ures, so the pathologists favored lymphoma or carcin-
oma of poor differentiation, which were the most
common malignancies of the duodenum. But further
immunohistochemical stains provided no evidence for
above diagnoses. By more careful observation, we found
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sinophilic nucleoli, which were one of the main features
of melanoma apart from visible melanin pigment, so ma-
lignant melanoma - a very rare malignancy in this site
should be taken into consideration. Expression of some
specific markers such as HMB45, Melan-A and S-100
protein is required to confirm our conjecture.
Optical treatment for malignant melanoma is an ex-
tensive and curative surgery, if possible, because other
methods including adjuvant radiotherapy, chemotherapy
and immunotherapy cannot offer definite treatment out-
come. The time of diagnosis and the presence of metas-
tases are supposed to represent major determinants of
prognosis [10,12]. The median survival after curative re-
section of primary malignant melanoma of the small in-
testine is 49 months [7]; the longest reported survival is
21 years [12]. To the best of our knowledge, our patient
refused chemotherapy and just used Chinese traditional
medicine intermittently. Now he has achieved disease-
free survival of more than 46 months without any evi-
dence of recurrence. The certain mechanism of Chinese
traditional medicine is still unclear and always be
regarded as complicated, sometimes even mysterious.
Nowadays, one of generally accepted opinions is that it
can enhance patients’ immunity efficiently. But melan-
oma is destined to behave aggressively, and widespread
metastases may present as a late complication. Further-
more, the Ki-67 labeling index in this case was greater
than 60% and the patient had one mesentery lymph
node involved. This highlights the need for close and
long-term follow-up.
Conclusion
In conclusion, PMMD is an extremely rare neoplastic le-
sion of the alimentary tract. There are no specific symp-
toms and radiologic imaging. Especially, the cases with
little melanin pigment or without visible melanin pig-
ment are very misleading. Definite diagnosis depends on
not only pathomorphology and immunohistochemical
stains, but also detailed history and thorough investiga-
tion, the latter are more important to exclude the preex-
istence or coexistence of a primary lesion elsewhere.
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